(Reuters) - Danish drugmaker Novo Nordisk and aid agency Red Cross have
teamed up to try to improve the treatment of chronic diseases among the
millions affected by conflicts and humanitarian crises in countries
such as Syria and Yemen.
WASHINGTON (Reuters) - The U.S. government on Tuesday
proposed tightening rules governing the amount of prescription opioid
painkillers that drugmakers can manufacture in a given year, in hopes of
reining in the deadly opioid epidemic.
TORONTO (Reuters) - Canada said on Tuesday
it is working with the U.S. Food and Drug Administration to access
supplies of Mylan N.V.'s EpiPen emergency allergy antidote amid a
growing shortage that has spared the United States.
April 18 (Reuters) - Renewed action and boosted funding to fight
malaria could prevent 350 million cases of the disease in the next five
years and save 650,000 lives across commonwealth countries, health
experts said on Wednesday.
YORK (Reuters) - Fans of the British royals have been awash in
glittering titillation over the upcoming nuptials of Prince Harry and
American actress Meghan Markle, but counselors warn there is a dark
side: extreme and potentially dangerous obsession.
(Reuters) - General Electric is raising its bet on biotechnology with
the launch of prefabricated manufacturing units for producing
virus-based gene and cell therapies, novel anti-cancer treatments and
ANGELES (Reuters) - A late-stage trial of Amgen Inc's experimental drug
Aimovig found that it reduced episodic migraines by at least half in 30
percent of patients who had failed up to four previous treatments,
while 14 percent of placebo patients achieved that goal, the company
said on Tuesday.
(Reuters) - UnitedHealth Group Inc , the largest U.S. health insurer, on Tuesday
reassured investors that the pervasive flu season did not crimp
first-quarter earnings as had been feared, boosting its shares as well
as those of rivals.
Health) - More visits to the emergency room by teens in Colorado are
related to marijuana use than in the past, suggesting an impact of the
drug's legalization that needs closer attention, researchers say.
China's aggressive hunt for overseas cobalt and lithium for electric
vehicles pushes up prices and causes a global shortage of the key
metals, South Korea is increasingly turning to such "urban mining" to
recover cobalt, lithium and other scarce metals from electronic waste.
Jim Drury reports.
You might like...
out our Reuters News Now daily briefing for hand-picked stories from
Reuters editors. It's all the news you need to start your day.